deltatrials
Completed NA INTERVENTIONAL 3-arm NCT04599907

Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating

An Evaluation of the Safety and Effectiveness of the N-SWEAT Patch for the Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating

Sponsor: Candesant Biomedical, Inc.

Updated 7 times since 2020 Last updated: Aug 29, 2023 Started: Oct 13, 2020 Primary completion: Jul 6, 2021 Completion: Dec 20, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Primary Axillary Hyperhidrosis, this trial is completed. The trial is conducted by Candesant Biomedical, Inc. and has accumulated 7 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotWithheld~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotWithheld~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshotRecruiting~Sep 2021 – ~Oct 2023 · 25 months · monthly snapshotActive Not Recruiting~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Oct 2023 — Jul 2024 [monthly]

    Completed NA

    Status: Active Not RecruitingCompleted

  4. Sep 2021 — Oct 2023 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  5. Apr 2021 — Sep 2021 [monthly]

    Recruiting NA

    Status: WithheldRecruiting · Phase: NoneNA

Show 2 earlier versions
  1. Jan 2021 — Apr 2021 [monthly]

    Withheld

  2. Nov 2020 — Jan 2021 [monthly]

    Withheld

    First recorded

Oct 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Candesant Biomedical, Inc.
Data source: Candesant Biomedical, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .